Search trials for
Showing NN of NN trials
Enrolling

A Study to Evaluate the Effect of Dapagliflozin on Renal Outcomes and Cardiovasc...

The purpose of this study is to evaluate the effect of dapagliflozin on renal outcomes and cardiovascular mortality in patients...

Enrolling

Study to Evaluate the Pharmacokinetics, Pharmacodynamics, and Safety of Vadadust...

This study will be conducted to assess the pharmacokinetics of vadadustat 600, 750, and 900 milligrams daily, and intravenous erythropoiesis-stimulating...

Want more information about clinical trials near you?

Register to get notifications about clinical trials in your area.
Register to Receive Updates
Enrolling

Efficacy and Safety Study to Evaluate Vadadustat for the Maintenance Treatment o...

A multicenter, randomized, open-label, active-controlled Phase 3 study for the maintenance treatment of anemia in subjects with NDD-CKD

Enrolling

Study of Etelcalceide in Pediatric Subjects With Secondary Hyperparathyroidism a...

Study of Etelcalcetide in Pediatric Subjects With Secondary Hyperparathyroidism and Chronic Kidney Disease on Hemodialysis

Enrolling

Study of Safety and Efficacy of LNP023 in Patients With Kidney Disease Caused by...

Efficacy and safety of LNP023 in IgAN patients

Enrolling

Anemia Study in Chronic Kidney Disease (CKD): Erythropoiesis Via a Novel Prolyl...

This will be an open-label, randomized, parallel-group study in hemodialysis-dependent (HD) participants with anemia associated with chronic kidney disease (CKD),...

Enrolling

Study of Vadadustat in Hemodialysis Patients With Anemia Switching From Epoetin...

This is a Phase 2 open-label efficacy, safety, and pharmacokinetic/pharmacodynamic (PK/PD) study to evaluate oral vadadustat for the treatment of...

Enrolling

Safety, Efficacy, PK and PD of CTAP101 (Calcifediol) ER Capsules for SHPT in HD...

Safety, Efficacy, PK and PD of CTAP101 (calcifediol) ER Capsules for SHPT in HD Patients VDI

Enrolling

An Extended Access Program for Bardoxolone Methyl in Patients With CKD (EAGLE)

This extended access study will assess the long-term safety and tolerability of bardoxolone methyl in qualified patients with chronic kidney...

Enrolling

The Mycophenolate Pregnancy Registry

The Mycophenolate Pregnancy Registry is designed as a prospective, observational registry collecting data regarding mycophenolate exposure during pregnancy, and pregnancy...

Enrolling

RENACTIF: Reduction of the Thrombotic Phenotype in Renal Insufficiency With N-Ac...

Chronic Kidney Disease (CKD) is a known risk factor of cardiovascular morbidity and mortality. In...

Enrolling

Savolitinib vs. Sunitinib in MET-driven PRCC

This study is designed for patients diagnosed with MET-driven, unresectable and locally advanced or metastatic Papillary Renal Cell Carcinoma. The...

Not Yet Enrolling

TicagRelor Or Clopidogrel in Severe and Terminal Chronic Kidney Disease Patients...

Ticagrelor is a potent and fast-acting P2Y12-ADP receptor antagonist recommended as first-line agent in ACS (2). This drug was associated...